Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical ImagingNuclear Medical

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1739179

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1739179

Medical Isotopes

PUBLISHED:
PAGES: 266 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Medical Isotopes Market to Reach US$8.8 Billion by 2030

The global market for Medical Isotopes estimated at US$5.9 Billion in the year 2024, is expected to reach US$8.8 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Stable Isotopes, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the Radioisotopes segment is estimated at 9.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 10.6% CAGR

The Medical Isotopes market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 10.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Medical Isotopes Market - Key Trends & Drivers Summarized

Why Are Medical Isotopes Central to Diagnostic Imaging and Targeted Therapeutics?

Medical isotopes have become indispensable to modern healthcare due to their wide-ranging applications in diagnostic imaging, targeted radiotherapy, and disease monitoring. These isotopes-radioactive atoms with specific half-lives-are used as tracers in nuclear medicine procedures to visualize organ function, detect tumors, assess metabolic activity, and monitor treatment efficacy. Key isotopes such as Technetium-99m (Tc-99m), Fluorine-18 (F-18), Iodine-131 (I-131), and Lutetium-177 (Lu-177) are widely deployed in SPECT, PET, and radiotherapeutic protocols.

With the growing incidence of cancer, cardiovascular disease, and neurological disorders, demand for nuclear imaging is increasing steadily, placing medical isotopes at the heart of precision diagnostics. Unlike traditional imaging, which reveals anatomical structure, isotopic scans provide physiological and biochemical information in real time-enabling early detection, more accurate staging, and personalized treatment plans. As the healthcare industry pivots toward value-based care and personalized medicine, medical isotopes are emerging as crucial enablers of data-rich, low-invasiveness diagnostic and therapeutic solutions.

How Are Production Technologies and Supply Chain Models Evolving to Meet Market Demand?

Medical isotope production is undergoing significant transformation to meet rising global demand and address longstanding supply vulnerabilities. Traditionally reliant on aging nuclear reactors using highly enriched uranium (HEU), isotope production is now shifting toward low enriched uranium (LEU) targets and non-reactor alternatives such as cyclotrons, linear accelerators, and generator-based systems. This transition is driven by both security concerns and regulatory pressure to reduce the use of weapons-grade nuclear materials in civilian applications.

Cyclotron-based production, particularly for short-lived isotopes like F-18, is gaining traction due to its ability to serve localized healthcare networks with minimal radioactive decay during transit. Generator-based solutions-such as molybdenum-99/technetium-99m (Mo-99/Tc-99m) systems-enable on-site isotope extraction, reducing dependency on centralized supply chains. Governments and private-sector stakeholders are investing in infrastructure to support isotope supply resilience, including backup reactors, regional cyclotron networks, and radiopharmaceutical manufacturing facilities. These developments are ensuring more stable, diversified, and scalable supply pathways for critical medical isotopes.

Which Clinical Fields and Procedural Volumes Are Driving Isotope Utilization Globally?

The highest demand for medical isotopes originates from oncology, cardiology, and neurology segments. In oncology, isotopes are used in both diagnostics (e.g., PET imaging with F-18 FDG to identify tumors and metastases) and therapeutics (e.g., I-131 for thyroid cancer or Lu-177 for prostate cancer). Nuclear imaging enables oncologists to assess tumor metabolism and treatment response earlier than morphological imaging techniques. Similarly, cardiac stress tests using Tc-99m sestamibi help detect coronary artery disease and myocardial perfusion deficits, contributing significantly to cardiovascular disease management.

Neurological applications are gaining prominence, especially for early detection of Alzheimer’s disease, Parkinson’s disease, and epilepsy. PET imaging with F-18 or carbon-based isotopes is used to map brain activity and evaluate neurodegeneration before physical symptoms manifest. In orthopedics and endocrinology, isotopes also help diagnose bone metastases and thyroid dysfunction. As population aging intensifies and non-communicable diseases become more prevalent globally, procedural volumes for nuclear medicine are rising-particularly in outpatient imaging centers, specialty cancer hospitals, and academic research institutions.

What Is Driving Long-Term Growth and Innovation in the Medical Isotopes Market?

The growth in the medical isotopes market is driven by rising diagnostic imaging volumes, expansion of targeted radionuclide therapy, regulatory modernization, and advancements in radiopharmaceutical R&D. The increasing adoption of theranostics-combining diagnostic and therapeutic capabilities into a single isotope platform-is creating significant commercial and clinical opportunities. For instance, Lu-177 and Actinium-225 are being developed to both image and treat metastatic cancer, allowing for better treatment matching and real-time response tracking.

Global public-private partnerships, such as the U.S. DOE/NNSA initiatives and EU Horizon projects, are funding next-generation isotope production technologies and radiopharmaceutical pipelines. Additionally, countries like Canada, India, South Korea, and South Africa are scaling up domestic isotope production to reduce dependence on limited global suppliers. The expansion of nuclear medicine departments in emerging markets and the integration of PET-CT and PET-MRI hybrid imaging systems are reinforcing demand.

Meanwhile, regulatory harmonization across markets and updated pharmacopoeia standards are streamlining approval pathways for novel radiotracers and labeling kits. As precision medicine and molecular diagnostics continue to advance, the strategic role of medical isotopes will deepen-positioning them as a cornerstone of high-performance, personalized healthcare infrastructure globally.

SCOPE OF STUDY:

The report analyzes the Medical Isotopes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Stable Isotopes, Radioisotopes); End-User (Hospitals, Diagnostic Centers, Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • ARTMS Inc.
  • Bayer AG
  • Bruce Power
  • BWXT Medical Ltd.
  • Cambridge Isotope Laboratories, Inc.
  • Cardinal Health, Inc.
  • Curium Pharma
  • Eckert & Ziegler
  • GE Healthcare
  • International Isotopes Inc.
  • ITM Isotope Technologies Munich SE
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • NTP Radioisotopes SOC Ltd
  • Nusano, Inc.
  • Orano Med
  • SHINE Technologies
  • Sotera Health (Nordion)
  • Theragnostics Ltd

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP34059

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Medical Isotopes - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Nuclear Imaging in Oncology Propels Growth in Medical Isotope Applications
    • Expansion of PET and SPECT Imaging Throws the Spotlight on Short-Lived Radioisotope Production
    • Increased Use of Technetium-99m in Diagnostic Procedures Strengthens Global Market Demand
    • Growth in Targeted Alpha Therapy Accelerates Innovation in Therapeutic Isotope Development
    • Surge in Thyroid and Bone Cancer Cases Drives Use of Iodine-131 and Samarium-153
    • Focus on Cyclotron and Non-Reactor-Based Isotope Production Enhances Supply Chain Resilience
    • Government Support for Domestic Isotope Production Facilities Spurs Regional Capacity Expansion
    • Technological Advancements in Radiopharmaceutical Synthesis Boost Clinical Efficiency
    • Growing Need for Companion Diagnostics Fuels Demand for Theranostic Isotope Pairing
    • Increasing Use of Lutetium-177 in Prostate Cancer Treatment Expands Targeted Radiotherapy Applications
    • Shortage of Reactor-Based Supply Chains Throws the Spotlight on Decentralized Production Models
    • Rising Investment in Cold Kits and Generator-Based Distribution Strengthens Delivery Infrastructure
    • Regulatory Streamlining for Isotope Approvals Accelerates Time-to-Market for Novel Radiotracers
    • Integration of Isotopes in Personalized Medicine Supports Patient-Specific Diagnostic Pathways
    • Emergence of Actinium-225 and Other Alpha Emitters Creates Opportunities in Rare Cancer Treatment
    • Improved Logistics and Half-Life Optimization Techniques Drive Efficiency in Regional Supply Chains
    • Collaboration Between Research Institutions and Pharma Companies Expands Clinical Research Pipeline
    • Use of AI in Radiopharmaceutical Planning Enhances Patient Scheduling and Isotope Utilization
    • Expansion of Radiopharmacy Networks in Emerging Markets Supports Accessibility of Diagnostic Isotopes
    • Global Aging Population and Increased Cancer Screening Rates Sustain Long-Term Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Medical Isotopes Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Medical Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stable Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stable Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Stable Isotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Radioisotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Medical Isotopes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • FRANCE
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Medical Isotopes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • INDIA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Medical Isotopes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Medical Isotopes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • AFRICA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!